statistiche ricercatore

PEGHIN, MADDALENA

Distribuzione geografica

Continente	#
NA - Nord America	3.655
EU - Europa	3.555
AS - Asia	2.541
SA - Sud America	306
AF - Africa	45
Continente sconosciuto - Info sul continente non disponibili	5
OC - Oceania	3
Totale	10.110

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	3.557
IT - Italia	2.368
SG - Singapore	1.084
CN - Cina	573
HK - Hong Kong	369
BR - Brasile	252
IE - Irlanda	245
GB - Regno Unito	199
VN - Vietnam	197
SE - Svezia	147
FR - Francia	126
RU - Federazione Russa	118
FI - Finlandia	108
BD - Bangladesh	89
IN - India	81
DE - Germania	79
CA - Canada	49
JP - Giappone	40
MX - Messico	38
NL - Olanda	36
ES - Italia	26
AT - Austria	25
UA - Ucraina	23
IQ - Iraq	22
AR - Argentina	18
PL - Polonia	18
TR - Turchia	17
CZ - Repubblica Ceca	15
NG - Nigeria	10
ZA - Sudafrica	10
CO - Colombia	9
VE - Venezuela	9
EC - Ecuador	8
EG - Egitto	8
MY - Malesia	7
SY - Repubblica araba siriana	7
AE - Emirati Arabi Uniti	6
PK - Pakistan	6
SA - Arabia Saudita	6
UZ - Uzbekistan	6
JO - Giordania	5
LT - Lituania	5
CH - Svizzera	4
DZ - Algeria	4
EU - Europa	4
ID - Indonesia	4
MA - Marocco	4
NP - Nepal	4
PH - Filippine	4
AU - Australia	3
AZ - Azerbaigian	3
CR - Costa Rica	3
KG - Kirghizistan	3
PY - Paraguay	3
UY - Uruguay	3
AL - Albania	2
BG - Bulgaria	2
CL - Cile	2
HN - Honduras	2
KE - Kenya	2
MD - Moldavia	2
PE - Perù	2
TN - Tunisia	2
UG - Uganda	2
AM - Armenia	1
AO - Angola	1
BB - Barbados	1
BE - Belgio	1
BH - Bahrain	1
DK - Danimarca	1
ET - Etiopia	1
GA - Gabon	1
GR - Grecia	1
HU - Ungheria	1
JM - Giamaica	1
KH - Cambogia	1
KR - Corea	1
LB - Libano	1
LU - Lussemburgo	1
MM - Myanmar	1
OM - Oman	1
PA - Panama	1
PR - Porto Rico	1
PT - Portogallo	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TT - Trinidad e Tobago	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	10.110

Salva come PNG Salva come JPEG

Città	#
Milan	1.683
San Jose	671
Singapore	552
Ashburn	491
Dallas	388
Hong Kong	362
Dublin	244
Council Bluffs	178
Beijing	163
Chicago	152
The Dalles	152
Rome	143
Boardman	116
Nyköping	114
Lauterbourg	106
Chandler	101
Princeton	96
London	95
Helsinki	93
Ho Chi Minh City	83
Los Angeles	76
Washington	60
New York	54
Santa Clara	43
Hanoi	40
Fairfield	38
Tokyo	38
Orem	33
São Paulo	29
Pune	27
Seattle	26
Ogden	24
Guangzhou	22
Mexico City	21
Chennai	20
Montreal	19
Nuremberg	19
Frankfurt am Main	18
Brooklyn	17
Houston	17
Warsaw	17
Amsterdam	16
San Diego	15
Shanghai	15
Brno	14
Buffalo	14
Atlanta	13
Hangzhou	13
Kilburn	13
Manchester	13
Assago	12
Dong Ket	12
Munich	12
Da Nang	11
Denver	11
Memphis	11
Poplar	11
San Francisco	11
Abuja	10
Boston	10
Jacksonville	10
Vienna	10
Falkenstein	9
Lappeenranta	9
Salt Lake City	9
Belo Horizonte	8
Brasília	8
Cambridge	8
Düsseldorf	8
Paris	8
Stockholm	8
Wilmington	8
Woodbridge	8
Changsha	7
Johannesburg	7
Las Vegas	7
Phoenix	7
Portsmouth	7
Rio de Janeiro	7
Varese	7
Aldeatejada	6
Ankara	6
Bologna	6
Cairo	6
Goiânia	6
Hounslow	6
New Bedfont	6
Ninh Bình	6
Tianjin	6
Toronto	6
Acton	5
Amman	5
Bogotá	5
Can Tho	5
Chiswick	5
Dalian	5
Damascus	5
Elk Grove Village	5
Genoa	5
New Delhi	5
Totale	7.148

Salva come PNG Salva come JPEG

Nome	#
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections	201
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality	160
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis	154
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)	146
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience	134
CARVs, CLAD, and CMV: A Call for Heightened Awareness in Lung Transplant Recipients	133
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study	130
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study	125
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains	123
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study	122
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant	122
How to manage KPC infections	115
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review	113
A look at clinical trial design for new antimicrobials for the adult population	112
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study	111
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	111
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study	110
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination	108
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study	107
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)	107
'Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients': authors' response	106
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients	102
10years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation	101
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa	100
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance	100
Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey	99
Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe	98
Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: active surveillance enhances recipient safety	97
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	95
Perioperative Antibiotic Stewardship in the Organ Transplant Setting	94
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study	93
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery	90
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study	88
Risk scores and surgery for infective endocarditis: in search of a good predictive score	88
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series	86
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance	86
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature	85
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study	84
The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014	84
Prevention and Treatment of Respiratory Virus Infection	83
Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization	83
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	83
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality	83
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients	82
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study	82
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis	81
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study	80
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam	80
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy	80
The management of multidrug-resistant Enterobacteriaceae	80
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery	79
Environmental variables associated with an increased risk of invasive aspergillosis	79
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia	79
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa	79
Mycobacterium chimaera infection after cardiac surgery: Catastrophic effects of delayed diagnosis	78
Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies	78
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections	78
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project	78
Cystic dystrophy of the pancreas in patient with only one previous cyst	78
When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections	78
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia	77
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	77
The current treatment landscape: candidiasis	77
Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients	77
Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study	77
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)	76
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis	76
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control Study	76
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors	76
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?	76
Fungal Endogenous Endophthalmitis Secondary to Magnusiomyces capitatus	76
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis	76
Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: A case report and review of the literature	75
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia	75
The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience	75
What Kind of Interventions Were Perceived as Effective Against Coronavirus-19 in Nursing Homes in Italy? A Descriptive Qualitative Study	75
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam	75
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	74
COVID-19 positive donor for solid organ transplantation	74
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe	74
Community-acquired pneumonia: is less more?	73
The safety of treatment options for acute bacterial skin and skin structure infections	73
Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options	73
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection	72
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient	71
Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization	71
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country	71
Recent concepts in fungal involvement in skin and soft tissue infections	70
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria	70
Treatment of Infections Due to MDR Gram-Negative Bacteria	70
New antibiotics for ventilator-associated pneumonia	69
Italian epidemiology of Gram negative bloodstream infections over 4-year period	68
The role of dalbavancin in skin and soft tissue infections	68
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study	68
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia	67
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19	67
Daptomycin-containing regimens for treatment of Gram-positive endocarditis	66
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?	66
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction	66
Estimated burden of fungal infections in Italy	65
Totale	8.899

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	64.899
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	64.899

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	18	0	0	0	0	0	0	0	0	0	0	0	18
2021/2022	219	0	1	0	1	2	2	0	0	112	22	2	77
2022/2023	628	48	3	7	75	44	209	2	85	94	29	16	16
2023/2024	2.797	386	446	421	537	610	200	35	47	45	17	11	42
2024/2025	1.780	7	39	323	81	59	100	89	74	236	154	153	465
2025/2026	4.722	283	330	399	536	322	187	1.044	275	482	349	307	208
Totale													10.226